Advertisement
Indian
Passenger vehicle sales increase 14% in August to 215,916 units: SIAM
According to the latest data by the Society of Indian Automobile Manufacturers (SIAM), two-wheeler sales also rose 3 per cent at 15,59,665 units, as compared to 15,14,196 units in the same month last year.
Motorcycle sales were at 10,32,476 units as against 9,37,486 units in August 2019, up 10.13 per cent.
IRDAI plans broad basing exclusive Carona covers, moots digital health insurance claim platform:Alamelu
“We are thinking of ways and means, sooner than later we will issue instructions on how standardised Covid-specific health insurance policies can be mainstreamed, renewed, features of porting migration so that Corona Rakshak and Corona Kavach policyholders continue to get a good cover not only for Covid but entire health sector.” said T.L. Alamelu,member (Non-Life),IRDAI on Friday while addressing an ASSOCHAM National e-Summit on Challenges, Opportunities & Way Forward for Health Insurance Under Covid Attack.
She also indicated that the regulator is currently is working on plans to develop a digital claim settlement mechanism involving all stakeholders – policyholders, insurers, TPAs, hospitals that could be stitched up with National Digital Health Mission.
Puri launches framework for cities to inculcate climate-sensitive approach to urban planning
At a virtual event, after launching ”Climate Smart Cities Assessment Framework 2.0”, Puri said, “It is estimated that climate change will impact the Indian GDP by 2-6 per cent on an annual basis.
“This means that our future development goals and investments will also be severely affected if we do not address climate risks now.”
DCGI issues notice to Serum Institute over Oxford’s Covid trial suspension
“Whereas, Serum Institute of India Pvt Ltd, Pune, till now has not informed the Central licensing authority regarding pausing the clinical trial carried out by AstraZeneca in other countries and also not submitted casualty analysis of the reported serious adverse event with the investigational vaccine for the continuation of phase 2 and 3 clinical trials of the subject vaccine in the country in light of the safety concerns,” said the show-cause notice accessed by PTI.
International
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Briefs
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Events
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Advertisement
Articles
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Features
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Data
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Interviews
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Facts
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
